Active substance
Results for the substance migalastat
1 result
About this active substance
Migalastat is a medication used for the treatment of Fabry disease, a rare genetic disorder caused by lipid accumulation in cells due to an enzyme deficiency. It works by stabilizing the alpha-galactosidase A enzyme, improving its function and reducing lipid buildup.
The medication is taken orally, usually once daily, and is indicated for patients with specific genetic mutations that respond to treatment. It is effective in reducing symptoms and slowing disease progression.
Side effects may include headache, nausea, abdominal pain, and fatigue. Regular monitoring is essential to assess the response to treatment.
Consult your doctor to discuss the benefits and risks of treatment with Migalastat. Follow all medical recommendations to ensure the therapy's effectiveness.
The medication is taken orally, usually once daily, and is indicated for patients with specific genetic mutations that respond to treatment. It is effective in reducing symptoms and slowing disease progression.
Side effects may include headache, nausea, abdominal pain, and fatigue. Regular monitoring is essential to assess the response to treatment.
Consult your doctor to discuss the benefits and risks of treatment with Migalastat. Follow all medical recommendations to ensure the therapy's effectiveness.